Jefferies Group's DGX Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 33,473 shares of Quest Diagnostics Incorporated (DGX) worth $6.56 M, representing 0.04% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in DGX, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2024, adding 49,198 shares. Largest reduction occurred in Q3 2024, reducing 38,032 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Quest Diagnostics Incorporated (DGX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Quest Diagnostics Incorporated (DGX) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -7,646 | Reduce 18.59% | 33,473 | $195.98 |
| Q4 2025 | +19,683 | Add 91.82% | 41,119 | $173.53 |
| Q3 2025 | -4,024 | Reduce 15.81% | 21,436 | $190.58 |
| Q2 2025 | -141 | Reduce 0.55% | 25,460 | $179.63 |
| Q1 2025 | +701 | Add 2.82% | 25,601 | $169.20 |
| Q4 2024 | +3,627 | Add 17.05% | 24,900 | $150.86 |
| Q3 2024 | -38,032 | Reduce 64.13% | 21,273 | $155.25 |
| Q2 2024 | +3,307 | Add 5.91% | 59,305 | $136.88 |
| Q1 2024 | +49,198 | Add 723.50% | 55,998 | $133.11 |
| Q4 2023 | -2,400 | Reduce 26.09% | 6,800 | $137.88 |
| Q3 2023 | +5,854 | Add 174.96% | 9,200 | $121.86 |
| Q2 2023 | +3,346 | New Buy | 3,346 | $140.56 |
| Q1 2023 | -5,170 | Sold Out | 0 | $0.00 |
| Q4 2022 | +5,170 | New Buy | 5,170 | $156.44 |
Jefferies Group's Quest Diagnostics Incorporated Investment FAQs
Jefferies Group first purchased Quest Diagnostics Incorporated (DGX) in Q4 2022, acquiring 5,170 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Quest Diagnostics Incorporated (DGX) for 14 quarters since Q4 2022.
Jefferies Group's largest addition to Quest Diagnostics Incorporated (DGX) was in Q1 2024, adding 55,998 shares worth $7.45 M.
According to the latest 13F filing for Q1 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 33,473 shares of Quest Diagnostics Incorporated (DGX), valued at approximately $6.56 M.
As of the Q1 2026 filing, Quest Diagnostics Incorporated (DGX) represents approximately 0.04% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Quest Diagnostics Incorporated (DGX) was 59,305 shares, as reported at the end of Q2 2024.